Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Identifying Gut Microbial Inducers of Biological Aging in the Colon 3U54CA274374-03S4 Christos Patriotis, Ph.D., M.Sc.
Grady, William Mallory

Fred Hutchinson Cancer Center
United States

Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus 5U2CCA271902-03 Matthew Young, Ph.D.
Grimm, Lars J

Duke University
United States

Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications 5R01CA271237-03 PAR-19-264 (R01 Clinical Trial Optional) Richard Mazurchuk, Ph.D.
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules 5R01CA252964-05 Claire Zhu, Ph.D.
Grogan, Eric L

Vanderbilt University Medical Center
United States

Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer 5U01CA152662-13 Guillermo Marquez, Ph.D.
Groninger, J. Hunter

Medstar Health Research Institute
United States

Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing 1R21CA299799-01 Brennan Streck, Ph.D., RN, M.P.H.
Gross, Howard M

Dayton Clinical Oncology Program
United States

Dayton Clinical Oncology Program 5UG1CA189957-11 Vanessa A. White, M.P.H.
Grossman, Douglas

University Of Utah
United States

Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma 1R21CA289101-01A1 Nick Hodges, Ph.D.
Grueber, Wesley B

Columbia University Health Sciences
United States

Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy 5R21CA274588-02 Rachel Altshuler, Ph.D.
Gudas, Lorraine J

Weill Medical Coll Of Cornell Univ
United States

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention 5R01CA270248-02